Literature DB >> 15895297

Inhibition of gastric cancer cell adhesion in nude mice by inraperitoneal phospholipids.

Marc Jansen1, Karl-Heinz Treutner, Petra Lynen Jansen, Sebastian Zuber, Jens Otto, Lothar Tietze, Volker Schumpelick.   

Abstract

Adhesion of tumor cells to mesothelial cells or extracellular matrix components is a pivotal step in developing peritoneal dissemination after gastric cancer. As phospholipids were found to reduce adhesion formation, especially at sites of peritoneal lesions, we assessed the inhibition of attachment of NUGC-4 gastric cancer cells by local treatment with phospholipids to the peritoneum in nude mice. Gastric cancer cells (1xl0(6)) suspended in either normal saline (controls) or phospholipid suspension 75 mg/kg body weight (PL75) or 150 mg/kg (PL150) were injected intraperitoneally into 90 female BALB/c nu/nu mice. The treatment groups were subdivided into animals with defined peritoneal lesions and animals without lesions. After 30 days the extent of peritoneal carcinosis and the Peritoneal Cancer Index were evaluated. Statistical analysis was performed with two factorial ANOVAs. The level of significance was adjusted according to Bonferrorni (alpha = 0.00278). During a 90-day observation period the survival rate was determined using the log rank test. After 30 days the intraperitoneal tumor volume was reduced by PL150 up to 0.6 ml (SEM 0.16) and 0.48 ml (SEM 0.09) in mice with peritoneal lesions compared to 0.9 ml (SEM 0.2) and 0.9 ml (SEM 0.1) in the control group (P = 0.04). The mean area of tumor adhesion amounted to 145 mm(2) (SEM 17) (P = 0.08) and 164 mm(2) (SEM 32.8) (P = 0.049) with peritoneal lesions after treatment with PL150 [controls: 216 mm(2) (SEM 28.5) and 245 mm(2) (SEM 29.3)]. The peritoneal cancer index was 16.4 (SEM 1.7) in the control group and 9 (SEM 1.68) with PL150 (P = 0.0002). In the subgroup with peritoneal lesions, the respective values were as follows: controls: 20.8 (SEM 0.85); PL 150:14.3 (SEM 1.07) (P = 0.0001). We found a prolonged survival rate after treatment with PL150. However, this effect was not significantly different to that seen in the control group. Treatment with PL75 had no significant influence. Phospholipids may be an efficacious and economic tool for reducing peritoneal tumor cell adhesion and consequently the development of peritoneal carcinosis after resection of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895297     DOI: 10.1007/s00268-005-7583-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  44 in total

1.  An assessment of the efficacy of anti-integrin alpha subunit monoclonal antibody production using affinity purified beta 1-integrin dimers as immunogen.

Authors:  A P Mould; J A Askari; S K Akiyama; K M Yamada; M J Humphries
Journal:  Biochem Soc Trans       Date:  1991-11       Impact factor: 5.407

2.  Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit.

Authors:  A P Mould; J A Askari; S i Aota; K M Yamada; A Irie; Y Takada; H J Mardon; M J Humphries
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

3.  Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells.

Authors:  P M van den Tol; E E van Rossen; C H van Eijck; F Bonthuis; R L Marquet; H Jeekel
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

4.  Sodium hyaluronate enhances colorectal tumour cell metastatic potential in vitro and in vivo.

Authors:  B Tan; J H Wang; Q D Wu; W O Kirwan; H P Redmond
Journal:  Br J Surg       Date:  2001-02       Impact factor: 6.939

5.  [Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma].

Authors:  R Broll; K Lembcke; C Stock; M Zingler; M Duchrow; H Schimmelpenning; M Strik; G Muller; P Kujath; H P Bruch
Journal:  Langenbecks Arch Chir       Date:  1996

6.  Prevention of peritoneal metastasis of cancer with dextran sulfate--an experimental study in mice.

Authors:  A Hagiwara; K Sawai; C Sakakura; M Shirasu; M Ohgaki; T Imanishi; J Yamasaki; T Togawa; T Takahashi
Journal:  Anticancer Drugs       Date:  1997-10       Impact factor: 2.248

7.  Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.

Authors:  E Bando; Y Yonemura; Y Takeshita; K Taniguchi; T Yasui; Y Yoshimitsu; S Fushida; T Fujimura; G Nishimura; K Miwa
Journal:  Am J Surg       Date:  1999-09       Impact factor: 2.565

8.  Expression of hydrophilic surfactant proteins by mesentery cells in rat and man.

Authors:  B Chailley-Heu; S Rubio; J P Rougier; R Ducroc; A M Barlier-Mur; P Ronco; J R Bourbon
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

9.  Morphogenesis of peritoneal metastasis in human gastric cancer.

Authors:  Y Kiyasu; S Kaneshima; S Koga
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

10.  Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.

Authors:  M Yashiro; Y S Chung; S Nishimura; T Inoue; M Sowa
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

View more
  3 in total

1.  The inhibition of tumor cell adhesion on human mesothelial cells (HOMC) by phospholipids in vitro.

Authors:  M Jansen; P Lynen Jansen; J Otto; T Kirtil; S Neuss; K-H Treutner; V Schumpelick
Journal:  Langenbecks Arch Surg       Date:  2006-03-14       Impact factor: 3.445

2.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study.

Authors:  Li Tang; Lie-Jun Mei; Xiao-Jun Yang; Chao-Qun Huang; Yun-Feng Zhou; Yutaka Yonemura; Yan Li
Journal:  J Transl Med       Date:  2011-05-07       Impact factor: 5.531

3.  Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats.

Authors:  Jens Otto; Petra Lynen Jansen; Stefan Lucas; Volker Schumpelick; Marc Jansen
Journal:  BMC Cancer       Date:  2007-06-21       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.